Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -4.770\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a: Nc1ccccc1C(=O)N(Cc1ccccc1)Cc1ccccc1
b: Cc1cccc(NC(=O)c2cnc3n(c2=O)CCS3)c1
c: CCCCC(=O)NC(=S)Nc1ccc(NC(=O)C(C)C)c(OC)c1
d: O=C1CN(C(=O)CN2CCOCC2)C(c2ccccc2)c2cc(Br)ccc2N1
Answer: d. O=C1CN(C(=O)CN2CCOCC2)C(c2ccccc2)c2cc(Br)ccc2N1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
7-bromo-4-(2-morpholin-4-ylacetyl)-5-phenyl-3,5-dihydro-1H-1,4-benzodiazepin-2-one